Biolidics Ltd.(SG:8YY)
S$0.02-0.00 (-10.00%)
SG:8YY
Biolidics Ltd. financials statements
S$0.02
At close:-0.00 (-10.00%)
Want to see SG:8YY full AI Analyst Report?
Biolidics Ltd. (8YY) Income Statement
3 Followers
Biolidics Ltd. Income Statement
Last quarter (Q2 2026), Biolidics Ltd.'s total revenue was S$3.31M, an increase of 7975.61% from the same quarter last year. In Q2, Biolidics Ltd.'s net income was S$288.00K. See Biolidics Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| S$ 5.26M | S$ 784.00K | S$ 277.00K | S$ 2.49M | S$ 2.31M | |
| S$ 1.94M | S$ 187.00K | S$ 146.00K | S$ 1.16M | S$ 483.00K | |
| S$ 5.16M | S$ 1.89M | S$ 1.14M | S$ 4.20M | S$ 3.79M | |
| Depreciation and Amortization | S$ 263.00K | S$ 120.00K | S$ 241.00K | S$ 1.18M | S$ 1.25M |
| S$ -3.65M | S$ -3.03M | S$ -1.16M | S$ -8.50M | S$ -4.58M | |
| S$ -3.22M | S$ -1.70M | S$ -996.00K | S$ -3.04M | S$ -3.31M | |
| S$ -772.00K | S$ -1.49M | S$ -518.00K | S$ -6.82M | S$ -2.73M | |
| S$ -3.99M | S$ -3.19M | S$ -1.51M | S$ -9.85M | S$ -6.04M | |
| S$ -3.96M | S$ -3.43M | S$ -2.49M | S$ -9.37M | S$ -5.98M | |
| Per Share Metrics | |||||
| Basic EPS | S$ -0.00 | S$ 0.00 | S$ 0.00 | S$ -0.03 | S$ -0.02 |
| Diluted EPS | S$ -0.00 | S$ 0.00 | S$ 0.00 | S$ -0.03 | S$ -0.02 |
| Weighted Average Shares Outstanding | 1.71B | 981.26M | 593.13M | 281.69M | 264.99M |
| Weighted Average Shares Outstanding (Diluted) | 1.71B | 981.26M | 593.13M | 281.69M | 265.21M |
Currency in SGD
